GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹ २,६६३.३०
arrow_downward
-०.९०%(-२४.३०) 1D
नोभेम्बर १८, १२:२७:५९ GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹ २,६९८.८०
High
₹ २,६९९.००
Low
₹ २,६५९.१०
Mkt. cap
४.५१ खरब
Avg. vol.
८९.४० हजार
Volume
११.७२ हजार
Dividend
२.१४%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.३५
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
Open
₹ २,६९८.८०
High
₹ २,६९९.००
Low
₹ २,६५९.१०
Mkt. cap
४.५१ खरब
Avg. vol.
८९.४० हजार
Volume
११.७२ हजार
Dividend
२.१४%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.३५
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Benzinga
·
२२ मिनेट पहिले
Stock Market: Will S&P 500 Open Up or Down Today?
BigGo Finance
·
८ घण्टा पहिले
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
Fox Business
·
११ घण्टा पहिले
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
Traders Union
·
५ घण्टा पहिले
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees३.१ हजार
Founded१९२४ नोभेम्बर १३
Headquarters-
SectorHealth Care
Industry-
Websiteindia-pharma.gsk.com